Biotech Values

[onco_investor]

RBC Capital Markets Healthcare Conference Panel Discussion

Cancer Treatments: Under the Radar Unique Late Stage Opportunities - Oncolytics CEO Dr. Brad Thompson will be a panel member.

Starts now if anybody is interested

2011 RBC Capital Markets Healthcare Conference

http://irgnews.com/coi/ONCY/Oncolytics-Biotech-Inc-to-Present-at-RBC-Capital-Markets-Healthcare-Conference

The link is at

http://www.wsw.com/webcast/rbc129/rbc129.panel1/


Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX:ONC.to) (NASDAQ:ONCY), will participate in a panel discussion at the RBC Capital Markets Healthcare Conference on Wednesday, March 2nd, 2011 at 9:00 a.m. ET. The conference takes place at the New York Palace Hotel on March 2nd and 3rd, 2011.

A live audio link to the webcast presentation is available or is on the company's website. It is recommended that listeners log on 10 minutes in advance of the presentation to register and download any necessary software.

An audio replay will be accessible approximately one hour following the presentation on the Oncolytics website.

About Oncolytics Biotech Inc.
Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of human trials including a Phase III trial in head and neck cancers using REOLYSIN®, its proprietary formulation of the human reovirus.